Anna Jarvis MD , Miriam Sheetz BS , Shriddha Nayak MD , Arthur Vaught MD , Marika Toscano MD , Kristin Darwin MD
{"title":"Severe maternal morbidity and risk of transplant rejection in pregnant patients with a history of solid-organ transplant","authors":"Anna Jarvis MD , Miriam Sheetz BS , Shriddha Nayak MD , Arthur Vaught MD , Marika Toscano MD , Kristin Darwin MD","doi":"10.1016/j.ajogmf.2025.101696","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>In 2023, 18,078 US women underwent solid organ transplants; over a third (n = 5547) were of reproductive age, receiving kidney (69.6%), liver (23.7%), or heart (9.0%) transplants. Successful pregnancies are feasible for transplant recipients, but these patients often face elevated pregnancy risks, including hypertension, gestational diabetes, pre-eclampsia, and preterm birth.</div></div><div><h3>Objective</h3><div>To determine rates of severe maternal morbidity (SMM) associated with prior kidney, liver, or heart transplant.</div></div><div><h3>Study Design</h3><div>This descriptive study was conducted using the TriNetX Research Network, a health research network with data from 95 health care organizations spanning 1/1/2010−10/29/2024. Patients aged 12-55 years were included if they underwent single solid organ transplant prior to pregnancy and had no prior history of transplant rejection. Pregnancy was defined by delivery CPT code indicating presence of a pregnancy. SMM was defined using Centers for Disease Control (CDC) ICD-10 codes for 21 indicators of SMM. The primary outcome was composite SMM during delivery hospitalization or within one year postpartum. Secondary outcomes included comparison of SMM in individuals with and without solid organ transplant history, as well as estimation of rates of individual indicators of SMM and postpartum transplant rejection over time.</div></div><div><h3>Results</h3><div>A total of 421 kidney, 192 liver, and 59 heart transplant recipients met inclusion criteria. Rates of composite SMM were greatest for heart transplant recipients (40.7%), with morbidity most often from pulmonary edema/acute heart failure (28.8%). This was followed by kidney transplant recipients (composite SMM 11.48%), with acute renal failure occurring in 9% of patients. Liver transplant recipients had the lowest composite SMM (7.48%). Rates of postpartum solid organ transplant rejection progressively increased at 1-, 2-, and 5-years post-delivery for all cohorts. Solid organ transplant rejection at 5-years was highest for heart transplant recipients (25.4%), followed by kidney (11.48%), and liver (7.48%).</div></div><div><h3>Conclusion</h3><div>Solid organ transplant recipients have significantly higher odds of composite SMM compared to pregnant non-transplant recipients. Among transplant recipients, patients with a history of heart transplant had the highest prevalence of composite non-transfusion SMM and highest rates of transplant rejection 5 years post-delivery. The impact of pregnancy on long-term outcomes in transplant recipients requires further study.</div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 7","pages":"Article 101696"},"PeriodicalIF":3.1000,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Obstetrics & Gynecology Mfm","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589933325000965","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
In 2023, 18,078 US women underwent solid organ transplants; over a third (n = 5547) were of reproductive age, receiving kidney (69.6%), liver (23.7%), or heart (9.0%) transplants. Successful pregnancies are feasible for transplant recipients, but these patients often face elevated pregnancy risks, including hypertension, gestational diabetes, pre-eclampsia, and preterm birth.
Objective
To determine rates of severe maternal morbidity (SMM) associated with prior kidney, liver, or heart transplant.
Study Design
This descriptive study was conducted using the TriNetX Research Network, a health research network with data from 95 health care organizations spanning 1/1/2010−10/29/2024. Patients aged 12-55 years were included if they underwent single solid organ transplant prior to pregnancy and had no prior history of transplant rejection. Pregnancy was defined by delivery CPT code indicating presence of a pregnancy. SMM was defined using Centers for Disease Control (CDC) ICD-10 codes for 21 indicators of SMM. The primary outcome was composite SMM during delivery hospitalization or within one year postpartum. Secondary outcomes included comparison of SMM in individuals with and without solid organ transplant history, as well as estimation of rates of individual indicators of SMM and postpartum transplant rejection over time.
Results
A total of 421 kidney, 192 liver, and 59 heart transplant recipients met inclusion criteria. Rates of composite SMM were greatest for heart transplant recipients (40.7%), with morbidity most often from pulmonary edema/acute heart failure (28.8%). This was followed by kidney transplant recipients (composite SMM 11.48%), with acute renal failure occurring in 9% of patients. Liver transplant recipients had the lowest composite SMM (7.48%). Rates of postpartum solid organ transplant rejection progressively increased at 1-, 2-, and 5-years post-delivery for all cohorts. Solid organ transplant rejection at 5-years was highest for heart transplant recipients (25.4%), followed by kidney (11.48%), and liver (7.48%).
Conclusion
Solid organ transplant recipients have significantly higher odds of composite SMM compared to pregnant non-transplant recipients. Among transplant recipients, patients with a history of heart transplant had the highest prevalence of composite non-transfusion SMM and highest rates of transplant rejection 5 years post-delivery. The impact of pregnancy on long-term outcomes in transplant recipients requires further study.
期刊介绍:
The American Journal of Obstetrics and Gynecology (AJOG) is a highly esteemed publication with two companion titles. One of these is the American Journal of Obstetrics and Gynecology Maternal-Fetal Medicine (AJOG MFM), which is dedicated to the latest research in the field of maternal-fetal medicine, specifically concerning high-risk pregnancies. The journal encompasses a wide range of topics, including:
Maternal Complications: It addresses significant studies that have the potential to change clinical practice regarding complications faced by pregnant women.
Fetal Complications: The journal covers prenatal diagnosis, ultrasound, and genetic issues related to the fetus, providing insights into the management and care of fetal health.
Prenatal Care: It discusses the best practices in prenatal care to ensure the health and well-being of both the mother and the unborn child.
Intrapartum Care: It provides guidance on the care provided during the childbirth process, which is critical for the safety of both mother and baby.
Postpartum Issues: The journal also tackles issues that arise after childbirth, focusing on the postpartum period and its implications for maternal health. AJOG MFM serves as a reliable forum for peer-reviewed research, with a preference for randomized trials and meta-analyses. The goal is to equip researchers and clinicians with the most current information and evidence-based strategies to effectively manage high-risk pregnancies and to provide the best possible care for mothers and their unborn children.